In vitro human skin decontamination efficacy of MOF-808 in decontamination lotion following exposure to the nerve agent VX

Fluoride Product Inhibition: New Insight into the Degradation of Nerve Agents by Zr-MOFs

Zirconium-based metal-organic frameworks (Zr-MOFs) have shown remarkable efficacy in catalytically degrading neurotoxic agents in recent years. However, the catalytic activity of Zr-MOFs can be inhibited due to the binding of phosphate degradation products to the Zr nodes. Here, we reported the inhibition effect of a nonphosphate substance, fluoride, which can deactivate Zr-MOF nodes for the degradation of GD and VX and simulate DEPPT. The experimental and theoretical calculation results reveal that the fluoride product during GD degradation shows much more significant suppression than phosphate. The phosphate products can depart from the Zr nodes completely by adding H2O molecules on the Zr nodes to reduce the energy barrier. However, the fluoride can replace the bridged μ3-OH groups and terminal -OH groups on Zr-oxo clusters irreversibly, changing the electric density of Zr nodes and eliminating the terminal -OH. Without the terminal -OH, the five-coordinate phosphorus intermediate cannot be formed, resulting in the inactivation of Zr-O-Zr sites. This study provides new insights into Zr-MOF catalyst deactivation mechanisms and may help to develop a new strategy to design MOFs with high anti-inhibition efficiency for the degradation of nerve agents.

A Miniaturized Method for Evaluating the Dynamic Gas-Phase Adsorption and Degradation of Sarin on Porous Adsorbents at Different Humidity Levels

Metal organic frameworks based on zirconium nodes (Zr-MOFs) have impressive adsorption capacities, and many can rapidly hydrolyze toxic organophosphorus nerve agents. They could thus potentially replace commonly used adsorbents in respiratory filters. However, current test methodologies are poorly adapted to screen the large number of available MOFs, and data for nerve agent adsorption by MOFs are scarce. This paper presents a miniaturized method for assessing the capacity of Zr-MOFs for dynamic gas phase adsorption and degradation of sarin (GB) into the primary hydrolysis product isopropyl methyl phosphonic acid (IMPA). The method was validated by comparing the dynamic adsorption capacities of activated carbon (AC) and NU-1000 for GB under dry and humid conditions. Under dry conditions, unimpregnated AC had a greater capacity for GB uptake (0.68 ± 0.06 g/g) than pelletized NU-1000 (0.36 ± 0.03 g/g). At 55% relative humidity (RH), the capacity of AC was largely unchanged (0.72 ± 0.10 g/g) but that of NU-1000 increased slightly, to 0.46 ± 0.10 g/g. However, NU-1000 exhibited poor water retention at 55% RH. For both adsorbents, the degree of hydrolysis of GB into IMPA was significantly greater at 55% RH than under dry conditions, but the overall degree of hydrolysis was limited in both cases. Further tests at higher relative humidities are needed to fully evaluate the ability of NU-1000 to degrade GB after adsorption from the gas phase. The proposed experimental setup uses very small amounts of both adsorbent material (20 mg) and toxic agent, making it ideal for assessing new MOFs. However, future methodological challenges are reliable generation of sarin at higher RH and exploring sensitive methods to monitor degradation products from nerve agents in real-time.

Development and Evaluation of a Topical Foam Formulation for Decontamination of Warfare Agents

Lewisite is a highly toxic and potent chemical warfare vesicating agent capable of causing pain, inflammation, and blistering. Therapeutic strategies that safely and effectively attenuate this damage are important. Early and thorough decontamination of these agents from skin is required to prevent their percutaneous absorption. In our studies, we used phenylarsine oxide (PAO), a surrogate for arsenicals, to simulate lewisite exposure. Various parameters such as determination of extraction solvents, skin extraction efficiency, donor volume, and donor concentration were optimized for decontamination of PAO. We aimed to develop a novel, easy to apply foam formulation that can decontaminate arsenicals. We screened various foaming agents, vehicles, and chemical enhancers for the development of foam. Lead formulation foam F30 was further characterized for foam density, foam expansion, foam liquid stability, foam volume stability, and foam gas fraction. The amount of PAO delivered into human skin in 30 min of exposure was 228.57 ± 28.44 μg/sq·cm. The amount of PAO remaining in human skin after decontamination with blank foam F30 was 50.09 ± 9.71, demonstrating an overall percentage decontamination efficiency of over 75%. Furthermore, the decontamination efficacy of F30 was also tested in the porcine skin model and results indicated an even higher decontamination efficacy. These studies demonstrated that the developed foam formulation can be used for effective decontamination of chemical warfare agents.

Effective Degradation of Novichok Nerve Agents by the Zirconium Metal-Organic Framework MOF-808

Novichoks are a novel class of nerve agents (also referred to as the A-series) that were employed in several poisonings over the last few years. This calls for the development of novel countermeasures that can be applied in protective concepts (e.g., protective clothing) or in decontamination methods. The Zr metal-organic framework MOF-808 has recently emerged as a promising catalyst in the hydrolysis of the V- and G-series of nerve agents as well as their simulants. In this paper, we report a detailed study of the degradation of three Novichok agents by MOF-808 in buffers with varying pH. MOF-808 is revealed to be a highly efficient and regenerable catalyst for Novichok agent hydrolysis under basic conditions. In contrast to the V- and G-series of agents, degradation of Novichoks is demonstrated to proceed in two consecutive hydrolysis steps. Initial extremely rapid P-F bond breaking is followed by MOF-catalyzed removal of the amidine group from the intermediate product. The intermediate thus acted as a competitive substrate that was rate-determining for the whole two-step degradation route. Under acidic conditions, the amidine group in Novichok A-230 is more rapidly hydrolyzed than the P-F bond, giving rise to another moderately toxic intermediate. This intermediate could in turn be efficiently hydrolyzed by MOF-808 under basic conditions. These experimental observations were corroborated by density functional theory calculations to shed light on molecular mechanisms.

Do cold weather temperatures affect the efficacy of skin decontamination?

Skin decontamination in cold weather temperatures might be challenging due to the aggravating circumstances. However, no information is available on the efficacy of commonly used procedures in winter conditions. Therefore, the efficacy of the reactive skin decontamination lotion (RSDL) and soapy water decontamination following skin exposure to the nerve agent VX was evaluated at three ambient air temperatures (-5°C, -15°C and room temperature). Experiments were performed in vitro using human dermatomed skin. The ability of RSDL to degrade VX at the three different air temperatures was separately evaluated. The ambient air temperature in experiments without decontamination did not influence the penetration rate of VX through skin. RSDL decontamination was highly efficient in removing VX from skin when performed in all three ambient temperatures, despite the slower agent degradation rate of VX at the lower temperatures. Decontamination with soapy water at RT resulted in an increased skin penetration of VX compared with the control without decontamination; however, in colder temperatures the VX skin penetration was similar to the corresponding control without decontamination. At RT, dry removal prior to washing with soapy water did not improve decontamination of VX compared with washing solely with soapy water. This study demonstrated high efficacy of RSDL decontamination following skin exposure to VX also at cold temperatures. The previously reported 'wash-in' effect of soapy water on VX skin penetration was reduced at cold temperatures. Altogether, this study found a scientific basis to establish guidelines for skin decontamination of chemical casualties at cold weather temperatures.

Towards catch-up therapy: evaluation of nucleophilic active pharmaceutical ingredients for the treatment of percutaneous VX poisoning, in-vial and in-vitro studies

Dermal exposure to low volatility organophosphorus chemical warfare agents (OP CWA) poses a great risk to the exposed person. Due to their lipophilic nature, these compounds rapidly absorb into the skin, leading to the formation of a "dermal reservoir" from which they slowly enter the bloodstream causing prolonged intoxication. Traditionally, strategies to counter the toxicity of such substances consist of chemical decontamination/physical removal of the residual agent from the skin surface (preferably as soon as possible following the exposure) and administration of antidotes in the case of intoxication signs. Hence, these strategies are unable to counter a substantial amount of the agent, which accumulates inthe dermal reservoir. More than a decade ago, the concept of a "catch-up therapy" intended to neutralize the dermal reservoir was suggested. Herein, we describe examples of potential "catch-up therapy" lotions - vehicles designed to deliver small nucleophilic molecules into the skin and potentially decompose the remaining CWA before it reaches the blood stream. Eleven nucleophilic compounds, based on approved drugs, were initially screened. They were then tested in various binary solutions, for their detoxification efficacy and degradation ability towards lipophilic OP CWA models such as dibutylphosphofluoridate and o-nitro-phenyl diphenyl phosphate, as well as the nerve agent VX, by means of kinetic ³¹P NMR and UV-Vis spectroscopy. Of these, the potassium and diethyl ammonium salts of acetohydroxamic acid (AHAK and AHA DEA) in (DMSO/H₂O 1:4) were found to be the most active nucleophiles, hydrolyzing VX in practical time scales (t_1/2 = 5.28 and 6.78 min, respectively). The vehicle solution DMSO/H₂O 1:4 promoted the penetration of substantial amounts of AHA K and AHA DEA through excised pig skin in in-vitro studies, suggesting that such formulations may serve as useful CWA nucleophilic scavengers for both on and within -skin detoxification. These findings may pave the way to a more efficacious treatment against low volatility OP CWA percutaneous poisoning.